Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers – Genetic Engineering & Biotechnology News (press release)
Genetic Engineering & Biotechnology News (press release) |
Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers
Genetic Engineering & Biotechnology News (press release) "We've found that immune cells start to be dysfunctional very early during tumor formation, but immunotherapy is not typically given until patients relapse and the cancer is advanced," says Miriam Merad, M.D., Ph.D., senior author of the lung cancer … Cell maps reveal how the body fights off cancer |
